Literature DB >> 24797894

Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein.

Naveena B Janakiram1, Altaf Mohammed1, Taylor Bryant1, Misty Brewer1, Laura Biddick1, Stan Lightfoot1, Mark L Lang2, Chinthalapally V Rao1.   

Abstract

High number of regulatory T cells (Tregs), both circulating and at the tumor site, often indicates a poor prognosis in CRC patient's possibly impairing natural killer (NK) cell function. To determine the role of Tregs in CRC development and their effects on NK cells, we created novel transgenic Rag-Apc mice that lack T cells and develop spontaneous intestinal tumors, and we adoptively transferred Tregs or transiently depleted NK cells during initial stages of tumorigenesis. In 6-weeks old Rag-Apc mice containing microscopic intestinal tumors adoptive transfer of Tregs or transient NK cell depletion dramatically associated with an increase in intestinal tumor multiplicity and tumor size, with significantly decreased survival rates. Importantly, Treg transfer increased small intestinal polyp formation up to 65% (P < 0.0005) and increased colon tumors multiplicities by 84% (P < 0.0001) with a significant decrease in NK cells as compared to control mice. Similarly, in NK depleted mice, colon tumor multiplicities increased up to 40% and small intestinal polyp formation up to 60% (P < 0.0001). Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)-γ systemically. Notably, IL-22 binding protein (IL-22 BP) was associated with NKs and a significant decrease was seen at the tumor site in mice adoptively transferred with Tregs or depleted of NK cells. Our results suggest that adoptive transfer of Tregs aggressively promote intestinal tumorigenesis by decreasing NK cell number and activity by modulating IL-22 BP.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ApcMin/+ mice; NK cells; Rag 1 mice; Tregs; colorectal cancer

Mesh:

Substances:

Year:  2014        PMID: 24797894     DOI: 10.1002/mc.22168

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  6 in total

1.  Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis.

Authors:  Naveena B Janakiram; Altaf Mohammed; Taylor Bryant; Stan Lightfoot; Peter D Collin; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-05

Review 2.  Islet cell transplant and the incorporation of Tregs.

Authors:  Adam Krzystyniak; Karolina Gołąb; Piotr Witkowski; Piotr Trzonkowski
Journal:  Curr Opin Organ Transplant       Date:  2014-12       Impact factor: 2.640

3.  Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer.

Authors:  Naveena B Janakiram; Altaf Mohammed; Taylor Bryant; Yuting Zhang; Misty Brewer; Ashley Duff; Laura Biddick; Anil Singh; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

4.  Chronic Trichuris muris infection causes neoplastic change in the intestine and exacerbates tumour formation in APC min/+ mice.

Authors:  Kelly S Hayes; Laura J Cliffe; Alison J Bancroft; Simon P Forman; Seona Thompson; Cath Booth; Richard K Grencis
Journal:  PLoS Negl Trop Dis       Date:  2017-06-26

Review 5.  Immunomodulation of NK Cells by Ionizing Radiation.

Authors:  Jiarui Chen; Xingyu Liu; Zihang Zeng; Jiali Li; Yuan Luo; Wenjie Sun; Yan Gong; Junhong Zhang; Qiuji Wu; Conghua Xie
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

6.  YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.

Authors:  Hua Sui; Lu Zhang; Kaijuan Gu; Ni Chai; Qing Ji; Lihong Zhou; Yan Wang; Junze Ren; Limei Yang; Bimeng Zhang; Jing Hu; Qi Li
Journal:  Cell Commun Signal       Date:  2020-07-16       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.